• Featured Product
  • KD/KO Validated

ARHGDIB Polyklonaler Antikörper

ARHGDIB Polyklonal Antikörper für IHC, IP, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IP, IHC, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 16122-1-AP

Synonyme

ARHGDIB, D4, GDIA2, GDID4, Ly GDI, LYGDI, RAP1GN1, Rho GDI 2, Rho GDI beta, RhoGDI2



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHL-60-Zellen, Jurkat-Zellen, K-562-Zellen, Raji-Zellen, Rattenmilzgewebe
Erfolgreiche IPRaji-Zellen
Erfolgreiche Detektion in IHChumanes Magenkrebsgewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:5000-1:50000
Immunpräzipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunhistochemie (IHC)IHC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

16122-1-AP bindet in WB, IP, IHC, ELISA ARHGDIB und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
In Publikationen genannte Reaktivitäthuman
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen ARHGDIB fusion protein Ag9078
Vollständiger Name Rho GDP dissociation inhibitor (GDI) beta
Berechnetes Molekulargewicht 201 aa, 23 kDa
Beobachtetes Molekulargewicht 27 kDa
GenBank-ZugangsnummerBC009200
Gene symbol ARHGDIB
Gene ID (NCBI) 397
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

ARHGDIB, also known as RhoGDI2, is a conserved member of the RhoGDI family and plays an important role in cell migrations. It regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. It is mainly in hematopoietic, endothelial, and epithelial cells. It has been linked to tumorigenesis and metastasis. RhoGDI2 expression is downregulated in several cancer types, such as bladder, lung and lymphoma, but is upregulated in prostate and gastric cancer.

Protokolle

Produktspezifische Protokolle
WB protocol for ARHGDIB antibody 16122-1-APProtokoll herunterladen
IHC protocol for ARHGDIB antibody 16122-1-APProtokoll herunterladen
IP protocol for ARHGDIB antibody 16122-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Nat Metab

Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression

Authors - Lin Qian
humanWB

Nat Immunol

Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity.

Authors - Jing Geng
humanWB

Mol Cancer

KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1.

Authors - Lei Liu
humanWB

Proteomics

Changes in the proteomic profile during the differential polarization status of the human monocyte-derived macrophage THP-1 cell line.

Authors - Fan Zhang
humanWB,IHC

Cancer Biomark

Systematic investigation of biomarker-like role of ARHGDIB in breast cancer.

Authors - Xiaonan Wang
  • KD Validated
humanWB

DNA Cell Biol

Rho GDP Dissociation Inhibitor (GDI) Beta Promotes Cell Proliferation and Invasion by Modulating the AKT Pathway in Hepatocellular Carcinoma.

Authors - Yang Fang